Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-May 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 67021000001112 | Oritavancin diphosphate | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 67041000001119 | Oritavancin diphosphate (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Oritavancin diphosphate | Is a | Substance with glycopeptide structure and antibacterial mechanism of action | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tenkasi 400mg powder for concentrate for solution for infusion vials (A. Menarini Farmaceutica Internazionale SRL) 3 vial | Has specific active ingredient | True | Oritavancin diphosphate | Inferred relationship | Existential restriction modifier | |
| Oritavancin 400mg powder for solution for infusion vials 3 vial | Has specific active ingredient | True | Oritavancin diphosphate | Inferred relationship | Existential restriction modifier | |
| Tenkasi 400mg powder for concentrate for solution for infusion vials (A. Menarini Farmaceutica Internazionale SRL) | Has specific active ingredient | True | Oritavancin diphosphate | Inferred relationship | Existential restriction modifier | |
| Oritavancin 400mg powder for solution for infusion vials | Has specific active ingredient | True | Oritavancin diphosphate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR